西班牙877例散发性视网膜色素变性的基因组全景
该研究对877例无家族史的西班牙散发性视网膜色素变性(sRP)患者进行经典基因分型或靶向二代测序(NGS),在38%的患者中检出致病变异,其中84.5%呈隐性遗传;仅6个常染色体隐性基因的双等位变异即解释50%的已解病例;常染色体显性和X连锁致病变异分别占7.6%和7.9%;经三联体分析确认20个新发变异,解释6%的病例;17%的已解病例被重新分类为其他视网膜病变表型。
要点
- NGS对sRP诊断有临床 utility,38%患者检出致病变异。
- 隐性遗传占已解病例84.5%,6个AR基因解释50%。
- 新发变异占6%,强调三联体分离分析的重要性。
核心结论
- NGS检测对散发性视网膜色素变性具有临床实用性,可扩展突变谱并提供准确的基因变异患病率。
- 新发变异在RP病因中的作用被低估,强调对散发病例进行分离分析及全面筛查X连锁和常染色体显性基因的重要性。
研究设计与样本
- 病例系列研究,纳入877例无家族史、临床诊断为视网膜色素变性的无关西班牙散发病例。
- 采用经典基因分型或靶向二代测序(NGS)进行研究,并用MLPA和基于芯片的比较基因组杂交确认NGS检出的拷贝数变异。
- 对携带新发变异的sRP病例进行定量荧光聚合酶链反应以确认亲子关系。
主要发现
- 在38%的研究患者中检出致病变异,其中84.5%的已解病例呈隐性遗传。
- 仅6个不同常染色体隐性基因的双等位变异即解释50%的已解病例。
- 常染色体显性和X连锁致病变异分别占7.6%和7.9%。
- 经三联体分析确认20个新发变异,解释6%的病例。
- 17%的已解sRP病例被重新分类为不同的视网膜病变表型。
关键数值与推荐
- 致病变异检出率38%;已解病例中隐性遗传占84.5%。
- 6个常染色体隐性基因的双等位变异解释50%的已解病例。
- 常染色体显性致病变异占7.6%,X连锁致病变异占7.9%。
- 新发变异占6%(20个经三联体分析确认)。
- 17%的已解病例被重新分类为其他视网膜病变表型。
临床怎么用
- 对散发性视网膜色素变性患者应进行全面的NGS检测,包括X连锁和常染色体显性基因筛查。
- 对检出新发变异的散发病例应进行三联体分离分析以确认新发状态。
- 基因检测结果有助于准确的遗传咨询和未来基因治疗入组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We aimed to unravel the molecular basis of sporadic retinitis pigmentosa (sRP) in the largest cohort reported to date. DESIGN: Case series. PARTICIPANTS: A cohort of 877 unrelated Spanish sporadic cases with a clinical diagnosis of retinitis pigmentosa (RP) and negative family history. METHODS: The cohort was studied by classic genotyping or targeted next-generation sequencing (NGS). Multiplex ligation-dependent probe amplification (MLPA) and array-based comparative genomic hybridization were performed to confirm copy number variations detected by NGS. Quantitative fluorescent polymerase chain reaction was assessed in sRP cases carrying de novo variants to confirm paternity. MAIN OUTCOME MEASURES: The study of the sRP cohort showed a high proportion of causal autosomal dominant (AD) and X-linked (XL) variants, most of them being de novo. RESULTS: Causative variants were identified in 38% of the patients studied, segregating recessively in 84.5% of the solved cases. Biallelic variants detected in only 6 different autosomal recessive genes explained 50% of the cases characterized. Causal AD and XL variants were found in 7.6% and 7.9% of cases, respectively. Remarkably, 20 de novo variants were confirmed after trio analysis, explaining 6% of the cases. In addition, 17% of the solved sRP cases were reclassified to a different retinopathy phenotype. CONCLUSIONS: This study highlights the clinical utility of NGS testing for sRP cases, expands the mutational spectrum, and provides accurate prevalence of mutated genes. Our findings evidence the underestimated role of de novo variants in the etiology of RP, emphasizing the importance of segregation analysis as well as comprehensive screening of genes carrying XL and AD variants in sporadic cases. Such in-depth study is essential for accurate family counseling and future enrollment in gene therapy-based treatments.
引用
- Martin-Merida I, Avila-Fernandez A, Del Pozo-Valero M, et al. Genomic Landscape of Sporadic Retinitis Pigmentosa: Findings from 877 Spanish Cases. Ophthalmology. 2019. PMID: 30902645. doi:10.1016/j.ophtha.2019.03.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。